Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus

Go back to Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus
(NASDAQ: IONS) Delayed: 56.00 +0.13 (0.23%)
Previous Close $55.87    52 Week High $62.68 
Open $55.16    52 Week Low $19.59 
Day High $56.22    P/E N/A 
Day Low $55.16    EPS $0.00 
Volume 208,330